Thymol; Exemption from the Requirement of a Tolerance
Thymol is exempted from tolerance requirements for residues on honey and honeycomb when used as a treatment. This is an EPA pesticide regulation, not a cosmetics rule, so no direct impact on MoCRA compliance.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Cosmetics and personal care businesses (indie brands, contract manufacturers, private-label makers, importers/distributors) that use thymol in products intended for honey or honeycomb, or that market such products as cosmetics. should confirm how it applies to their specific situation before acting. There is a time constraint attached: None. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
EPA exempted thymol from the requirement of a tolerance for residues on honey, honeycomb, and honeycomb with honey when used as a treatment. This is a pesticide tolerance exemption, not a cosmetics regulation.
Who it affects
Cosmetics and personal care businesses (indie brands, contract manufacturers, private-label makers, importers/distributors) that use thymol in products intended for honey or honeycomb, or that market such products as cosmetics.
What you must do
No action required for cosmetics compliance under MoCRA. However, if your product contains thymol and is used on bees or honeycomb, ensure compliance with EPA pesticide regulations.
Deadline
None
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Grants Seventh Approval under the National Priority Voucher Pilot Program
- FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
- FDA Expands AI Capabilities and Completes Data Platform Consolidation
- FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection